COFCO Biotechnology Co., Ltd. (SHE:000930)
China · Delayed Price · Currency is CNY 4.850
0.00 (0.00%)
Jun 11, 2026, 3:04 PM CST
COFCO Biotechnology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 9,004 | 10,712 | 10,321 | 12,382 | 15,594 | 20,280 | |
Market Cap Growth | -12.45% | 3.78% | -16.64% | -20.60% | -23.11% | 29.09% |
Enterprise Value | 10,822 | 12,747 | 13,093 | 15,361 | 17,467 | 22,540 |
Last Close Price | 4.85 | 5.77 | 5.55 | 6.64 | 7.77 | 9.84 |
PE Ratio | - | 279.19 | 410.73 | - | 14.73 | 17.95 |
Forward PE | - | 17.58 | 17.58 | 17.58 | 17.58 | 17.58 |
PS Ratio | 0.53 | 0.61 | 0.52 | 0.61 | 0.78 | 0.86 |
PB Ratio | 0.83 | 0.97 | 0.95 | 1.14 | 1.25 | 1.73 |
P/TBV Ratio | 0.96 | 1.11 | 1.08 | 1.31 | 1.40 | 1.95 |
P/FCF Ratio | 20.75 | 9.13 | - | 9.36 | 109.31 | 5.43 |
P/OCF Ratio | 7.68 | 5.80 | 66.24 | 6.32 | 22.01 | 4.19 |
EV/Sales Ratio | 0.64 | 0.73 | 0.65 | 0.75 | 0.88 | 0.96 |
EV/EBITDA Ratio | 25.72 | 25.24 | 23.33 | 326.11 | 8.88 | 10.64 |
EV/EBIT Ratio | - | 1067.76 | 174.21 | - | 11.44 | 13.38 |
EV/FCF Ratio | 24.94 | 10.86 | - | 11.61 | 122.43 | 6.04 |
Debt / Equity Ratio | 0.30 | 0.22 | 0.41 | 0.34 | 0.26 | 0.29 |
Debt / EBITDA Ratio | 7.69 | 4.64 | 7.60 | 50.53 | 1.62 | 1.59 |
Debt / FCF Ratio | 7.45 | 2.07 | - | 2.75 | 22.61 | 0.91 |
Net Debt / Equity Ratio | 0.13 | 0.00 | 0.23 | 0.20 | 0.18 | 0.19 |
Net Debt / EBITDA Ratio | 3.53 | -0.11 | 4.47 | 45.90 | 1.12 | 1.08 |
Net Debt / FCF Ratio | 3.27 | -0.05 | -7.67 | 1.63 | 15.46 | 0.61 |
Asset Turnover | 0.96 | 1.03 | 1.18 | 1.18 | 1.10 | 1.22 |
Inventory Turnover | 5.42 | 7.09 | 7.13 | 6.29 | 4.57 | 4.67 |
Quick Ratio | 0.55 | 0.71 | 0.57 | 0.55 | 0.50 | 0.47 |
Current Ratio | 1.17 | 1.22 | 1.17 | 1.17 | 1.49 | 1.37 |
Return on Equity (ROE) | -1.10% | 0.42% | 0.42% | -5.28% | 8.74% | 10.02% |
Return on Assets (ROA) | -0.33% | 0.04% | 0.28% | -1.51% | 5.28% | 5.46% |
Return on Invested Capital (ROIC) | -0.80% | 0.06% | 0.20% | -3.03% | 8.29% | 8.91% |
Return on Capital Employed (ROCE) | -0.80% | 0.10% | 0.70% | -3.70% | 11.80% | 13.50% |
Earnings Yield | -1.37% | 0.36% | 0.24% | -4.86% | 6.79% | 5.57% |
FCF Yield | 4.82% | 10.96% | -3.17% | 10.69% | 0.92% | 18.40% |
Dividend Yield | 0.62% | 0.52% | - | - | 7.33% | 2.49% |
Payout Ratio | - | 216.50% | 371.98% | - | 52.41% | 24.55% |
Buyback Yield / Dilution | 0.53% | 0.43% | -1.08% | 0.85% | -0.45% | 0.18% |
Total Shareholder Return | 1.15% | 0.95% | -1.08% | 0.85% | 6.88% | 2.67% |